Lawrence Long

Summary

Publications

  1. doi request reprint The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa
    Lawrence Long
    Health Economics and Epidemiology Research Office, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa
    AIDS 24:915-9. 2010
  2. pmc Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort
    Lawrence Long
    Health Economics and Epidemiology Research Office, Wits Health Consortium, Johannesburg, South Africa
    PLoS Med 8:e1001055. 2011
  3. pmc Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa
    Bruce A Larson
    Department of International Health, Center for Global Health and Development, Boston University School of Public Health, 801 Massachusetts Avenue, Crosstown 3rd Floor, Boston, MA 02118, USA
    J Acquir Immune Defic Syndr 61:e13-7. 2012
  4. pmc Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
    Kathryn Schnippel
    Health Economics and Epidemiology Research Office, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
    Trop Med Int Health 17:1142-51. 2012
  5. doi request reprint Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment
    Alana T Brennan
    Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    AIDS 25:2027-36. 2011
  6. pmc The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa
    Kate Shearer
    Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 8:e71719. 2013
  7. doi request reprint Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa
    Kathryn Schnippel
    Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    Trop Med Int Health 18:109-16. 2013
  8. pmc The impact and cost of scaling up GeneXpert MTB/RIF in South Africa
    Gesine Meyer-Rath
    Health Economics and Epidemiology Research Office HE2RO, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 7:e36966. 2012

Collaborators

Detail Information

Publications8

  1. doi request reprint The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa
    Lawrence Long
    Health Economics and Epidemiology Research Office, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa
    AIDS 24:915-9. 2010
    ..This information is crucial for planning and budgeting...
  2. pmc Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort
    Lawrence Long
    Health Economics and Epidemiology Research Office, Wits Health Consortium, Johannesburg, South Africa
    PLoS Med 8:e1001055. 2011
    ..This study evaluated the cost-effectiveness of down-referring stable antiretroviral therapy (ART) patients from a doctor-managed, hospital-based ART clinic to a nurse-managed primary health care facility in Johannesburg, South Africa...
  3. pmc Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa
    Bruce A Larson
    Department of International Health, Center for Global Health and Development, Boston University School of Public Health, 801 Massachusetts Avenue, Crosstown 3rd Floor, Boston, MA 02118, USA
    J Acquir Immune Defic Syndr 61:e13-7. 2012
    ..We report results from this pilot program for patients testing positive (n = 508) from May to October 2010...
  4. pmc Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
    Kathryn Schnippel
    Health Economics and Epidemiology Research Office, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
    Trop Med Int Health 17:1142-51. 2012
    ..We used recent South African data to compare the cost of placing Xpert at points of TB treatment (all primary clinics and hospitals) with the cost of placement at sub-district laboratories...
  5. doi request reprint Outcomes of stable HIV-positive patients down-referred from a doctor-managed antiretroviral therapy clinic to a nurse-managed primary health clinic for monitoring and treatment
    Alana T Brennan
    Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    AIDS 25:2027-36. 2011
    ....
  6. pmc The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa
    Kate Shearer
    Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 8:e71719. 2013
    ..We sought to compare outcomes among those taking nevirapine vs. efavirenz with tenofovir and lamivudine...
  7. doi request reprint Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa
    Kathryn Schnippel
    Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    Trop Med Int Health 18:109-16. 2013
    ..To inform new strategies for MDR-TB management, we estimated the per-patient cost (USD 2011) of inpatient MDR-TB treatment...
  8. pmc The impact and cost of scaling up GeneXpert MTB/RIF in South Africa
    Gesine Meyer-Rath
    Health Economics and Epidemiology Research Office HE2RO, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 7:e36966. 2012
    ....